apraclonidine has been researched along with Recrudescence in 2 studies
apraclonidine: relieves postoperative intraocular pressure following trabeculoplasty; RN given refers to parent cpd
apraclonidine : An imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group.
Excerpt | Relevance | Reference |
---|---|---|
"We document the recurrence of a CSMD in a patient subsequent to the instillation of topical ocular hypotensive medications and its resolution on discontinuation of therapy." | 1.35 | Recurrent serous macular detachment after topical ocular hypotensive medication. ( Besada, E; Frauens, BJ; Shechtman, D, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Besada, E | 1 |
Shechtman, D | 1 |
Frauens, BJ | 1 |
Jampel, HD | 1 |
2 other studies available for apraclonidine and Recrudescence
Article | Year |
---|---|
Recurrent serous macular detachment after topical ocular hypotensive medication.
Topics: Administration, Topical; Antihypertensive Agents; Clonidine; Drug Combinations; Drug Therapy, Combin | 2008 |
Hypotony following instillation of apraclonidine for increased intraocular pressure after trabeculoplasty.
Topics: Aged; Clonidine; Humans; Intraocular Pressure; Male; Ocular Hypertension; Recurrence; Trabeculectomy | 1989 |